Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Invested Capital (2020 - 2025)

Historic Invested Capital for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $276.0 million.

  • RxSight's Invested Capital fell 46.56% to $276.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $276.0 million, marking a year-over-year decrease of 46.56%. This contributed to the annual value of $281.2 million for FY2024, which is 7537.7% up from last year.
  • As of Q3 2025, RxSight's Invested Capital stood at $276.0 million, which was down 46.56% from $278.0 million recorded in Q2 2025.
  • RxSight's Invested Capital's 5-year high stood at $281.2 million during Q4 2024, with a 5-year trough of -$273.4 million in Q2 2021.
  • Moreover, its 5-year median value for Invested Capital was $177.6 million (2021), whereas its average is $177.2 million.
  • Examining YoY changes over the last 5 years, RxSight's Invested Capital showed a top increase of 15486.03% in 2022 and a maximum decrease of 2876.35% in 2022.
  • Over the past 5 years, RxSight's Invested Capital (Quarter) stood at $178.0 million in 2021, then dropped by 26.93% to $130.1 million in 2022, then increased by 23.29% to $160.4 million in 2023, then skyrocketed by 75.38% to $281.2 million in 2024, then fell by 1.87% to $276.0 million in 2025.
  • Its Invested Capital stands at $276.0 million for Q3 2025, versus $278.0 million for Q2 2025 and $279.3 million for Q1 2025.